CGC
Price
$0.65
Change
-$0.03 (-4.41%)
Updated
Oct 30 closing price
Capitalization
276.03M
6 days until earnings call
Intraday BUY SELL Signals
TLRY
Price
$2.53
Change
-$0.11 (-4.17%)
Updated
Oct 30 closing price
Capitalization
355.27M
Intraday BUY SELL Signals
Interact to see
Advertisement

CGC vs TLRY

CGC vs TLRY Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CGC vs. TLRY commentary
Oct 31, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGC is a Hold and TLRY is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for CGC with price predictions
Oct 30, 2026

CGC in +0.98% Uptrend, growing for three consecutive days on October 20, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where CGC advanced for three days, in 162 of 199 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 16 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 22 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

CGC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 30, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CGC as a result. In 76 of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CGC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for CGC entered a downward trend on October 30, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 17 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.401) is normal, around the industry mean (8.346). P/E Ratio (-0.974) is within average values for comparable stocks, (-1.638). CGC's Projected Growth (PEG Ratio) (7.200) is slightly higher than the industry average of (2.152). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (1.549) is also within normal values, averaging (178.797).

The Tickeron Price Growth Rating for this company is 85 (best 1 - 100 worst), indicating slightly worse than average price growth. CGC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CGC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.

A.I.Advisor
a Summary for TLRY with price predictions
Oct 30, 2026

Momentum Indicator for TLRY turns negative, indicating new downward trend

TLRY saw its Momentum Indicator move below the 0 level on September 28, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 78 similar instances where the indicator turned negative. In 72 of the 78 cases, the stock moved further down in the following days. The odds of a decline are at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for TLRY turned negative on September 29, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 40 similar instances when the indicator turned negative. In 36 of the 40 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TLRY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for TLRY entered a downward trend on October 30, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 14 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 22 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +4.71% 3-day Advance, the price is estimated to grow further. Considering data from situations where TLRY advanced for three days, in 166 of 208 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.

TLRY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 12 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 23 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.220) is normal, around the industry mean (8.346). P/E Ratio (-2.321) is within average values for comparable stocks, (-1.638). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.152). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (0.481) is also within normal values, averaging (178.797).

The Tickeron Price Growth Rating for this company is 91 (best 1 - 100 worst), indicating slightly worse than average price growth. TLRY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 93 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TLRY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.

FUNDAMENTALS RATINGS
CGC vs TLRY: Fundamental Ratings
CGC
TLRY
OUTLOOK RATING
1..100
655
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
23
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9793
PRICE GROWTH RATING
1..100
8591
P/E GROWTH RATING
1..100
1712
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TLRY's Valuation (23) in the Biotechnology industry is somewhat better than the same rating for CGC (85) in the Agricultural Commodities Or Milling industry. This means that TLRY’s stock grew somewhat faster than CGC’s over the last 12 months.

TLRY's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as CGC (100) in the Agricultural Commodities Or Milling industry. This means that TLRY’s stock grew similarly to CGC’s over the last 12 months.

TLRY's SMR Rating (93) in the Biotechnology industry is in the same range as CGC (97) in the Agricultural Commodities Or Milling industry. This means that TLRY’s stock grew similarly to CGC’s over the last 12 months.

CGC's Price Growth Rating (85) in the Agricultural Commodities Or Milling industry is in the same range as TLRY (91) in the Biotechnology industry. This means that CGC’s stock grew similarly to TLRY’s over the last 12 months.

TLRY's P/E Growth Rating (12) in the Biotechnology industry is in the same range as CGC (17) in the Agricultural Commodities Or Milling industry. This means that TLRY’s stock grew similarly to CGC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CGCTLRY
RSI
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 12 days ago
81%
Bullish Trend 26 days ago
80%
Declines
ODDS (%)
Bearish Trend 10 days ago
90%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
COMPARISON
Comparison
Oct 31, 2026
Stock price -- (CGC: $0.65 vs. TLRY: $2.53)
Brand notoriety: CGC and TLRY are both notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CGC: 102% vs. TLRY: 120%
Market capitalization -- CGC: $276.03M vs. TLRY: $355.27M
CGC [@Pharmaceuticals: Generic] is valued at $276.03M. TLRY’s [@Pharmaceuticals: Generic] market capitalization is $355.27M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $2.12K to $68.49B. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGC’s FA Score shows that 1 FA rating(s) are green while TLRY’s FA Score has 2 green FA rating(s).

  • CGC’s FA Score: 1 green, 4 red.
  • TLRY’s FA Score: 2 green, 3 red.
According to our system of comparison, TLRY is a better buy in the long-term than CGC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGC’s TA Score shows that 4 TA indicator(s) are bullish while TLRY’s TA Score has 4 bullish TA indicator(s).

  • CGC’s TA Score: 4 bullish, 3 bearish.
  • TLRY’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, CGC is a better buy in the short-term than TLRY.

Price Growth

CGC (@Pharmaceuticals: Generic) experienced а -3.45% price change this week, while TLRY (@Pharmaceuticals: Generic) price change was -9.96% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -0.14%. For the same industry, the average monthly price growth was -9.43%, and the average quarterly price growth was +3.28%.

Reported Earning Dates

CGC is expected to report earnings on Nov 06, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-0.14% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

View a ticker or compare two or three
CGC
Daily Signal:
Gain/Loss:
TLRY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
VCIT79.690.18
+0.23%
Vanguard Intermediate-Term Corporate Bond ETF (VCIT)
KORP45.150.06
+0.13%
American Century Diversified Corporate Bond ETF (KORP)
RNEM55.45-0.02
-0.04%
First Trust Emerging Markets Equity Select ETF (RNEM)
DLFE32.47-0.23
-0.69%
FT Vest U.S. Equity Dual Directional Buffer ETF - February
HBTA30.75-1.07
-3.35%
Horizon Expedition Plus ETF